Abbott India is currently trading at Rs. 8613.00, up by 31.65 points or 0.37% from its previous closing of Rs. 8581.35 on the BSE.
The scrip opened at Rs. 8614.35 and has touched a high and low of Rs. 8620.00 and Rs. 8610.30 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 8834.05 on 10-Sep-2018 and a 52 week low of Rs. 6300.00 on 14-Jun-2018.
Last one week high and low of the scrip stood at Rs. 8670.00 and Rs. 7930.00 respectively. The current market cap of the company is Rs. 18304.89 crore.
The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.04% and 15.98% respectively.
Abbott has unveiled sensor enabled HD grid mapping catheter, a device that can be inserted in the body to treat diseases or perform surgical procedures, in India.
The company has launched the product after receiving clearance from the US Food and Drug Administration (USFDA) last year.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.
